Literature DB >> 22009222

Recurrent trisomy and Robertsonian translocation of chromosome 14 in murine iPS cell lines.

Qian Chen1, Xiaoyun Shi, Cornelia Rudolph, Yong Yu, Ding Zhang, Xiaoyu Zhao, Sabine Mai, Gang Wang, Brigitte Schlegelberger, Qinghua Shi.   

Abstract

Induced pluripotent stem (iPS) cells have greatly provoked people's interest due to their enormous potential of clinical applications. Increasing care is taken with the genetic safety of iPS cells. However, up to now, the chromosomal integrity of murine iPS (miPS) cells has been largely unknown. We have observed recurrent trisomy and/or Robertsonian translocation (Rb) of chromosome 14 in six out of nine independent miPS cell lines from three laboratories by G-banding, fluorescence in situ hybridization (FISH) and spectral karyotyping (SKY) analyses, while all the miPS cell lines were derived from mouse embryonic fibroblasts (MEFs) or neural precursor cells (NPCs) with a normal karyotype. The miPS cells with trisomy and/or Rb of chromosome 14 showed growth advantage over the miPS cells with a normal karyotype. We found a significantly higher frequency of Rbs in the miPS cell lines induced with c-Myc than those without c-Myc. Our findings demonstrate that miPS cell lines have the propensity for chromosomal aberrations and there is an obvious correlation between the extent of chromosomal aberrations in miPS cells and the transcriptional factors used for their reprogramming. Therefore, our study raises awareness of the need for improvements of the induction conditions of miPS cells in order to avoid the chromosomal aberrations and ensure future safe applications.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22009222     DOI: 10.1007/s10577-011-9239-y

Source DB:  PubMed          Journal:  Chromosome Res        ISSN: 0967-3849            Impact factor:   5.239


  33 in total

1.  Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors.

Authors:  Wenlin Li; Wei Wei; Saiyong Zhu; Jinliang Zhu; Yan Shi; Tongxiang Lin; Ergeng Hao; Alberto Hayek; Hongkui Deng; Sheng Ding
Journal:  Cell Stem Cell       Date:  2008-12-18       Impact factor: 24.633

2.  Improved efficiency and pace of generating induced pluripotent stem cells from human adult and fetal fibroblasts.

Authors:  Prashant Mali; Zhaohui Ye; Holly H Hommond; Xiaobing Yu; Jeff Lin; Guibin Chen; Jizhong Zou; Linzhao Cheng
Journal:  Stem Cells       Date:  2008-05-29       Impact factor: 6.277

3.  Copy number variation and selection during reprogramming to pluripotency.

Authors:  Samer M Hussein; Nizar N Batada; Sanna Vuoristo; Reagan W Ching; Reija Autio; Elisa Närvä; Siemon Ng; Michel Sourour; Riikka Hämäläinen; Cia Olsson; Karolina Lundin; Milla Mikkola; Ras Trokovic; Michael Peitz; Oliver Brüstle; David P Bazett-Jones; Kari Alitalo; Riitta Lahesmaa; Andras Nagy; Timo Otonkoski
Journal:  Nature       Date:  2011-03-03       Impact factor: 49.962

4.  Incidence of mosaic cell lines in vivo and malsegregation of chromosome 21 in lymphocytes in vitro of trisomy 21 patients: detection by fluorescence in situ hybridization on binucleated lymphocytes.

Authors:  Q Shi; I D Adler; J Zhang; X Zhang; X Shan; R Martin
Journal:  Hum Genet       Date:  2000-01       Impact factor: 4.132

5.  Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture.

Authors:  Louise C Laurent; Igor Ulitsky; Ileana Slavin; Ha Tran; Andrew Schork; Robert Morey; Candace Lynch; Julie V Harness; Sunray Lee; Maria J Barrero; Sherman Ku; Marina Martynova; Ruslan Semechkin; Vasiliy Galat; Joel Gottesfeld; Juan Carlos Izpisua Belmonte; Chuck Murry; Hans S Keirstead; Hyun-Sook Park; Uli Schmidt; Andrew L Laslett; Franz-Josef Muller; Caroline M Nievergelt; Ron Shamir; Jeanne F Loring
Journal:  Cell Stem Cell       Date:  2011-01-07       Impact factor: 24.633

6.  Reprogramming of human somatic cells to pluripotency with defined factors.

Authors:  In-Hyun Park; Rui Zhao; Jason A West; Akiko Yabuuchi; Hongguang Huo; Tan A Ince; Paul H Lerou; M William Lensch; George Q Daley
Journal:  Nature       Date:  2007-12-23       Impact factor: 49.962

7.  ATM-deficient thymic lymphoma is associated with aberrant tcrd rearrangement and gene amplification.

Authors:  Shan Zha; Craig H Bassing; Takaomi Sanda; James W Brush; Harin Patel; Peter H Goff; Michael M Murphy; Suprawee Tepsuporn; Richard A Gatti; A Thomas Look; Frederick W Alt
Journal:  J Exp Med       Date:  2010-06-21       Impact factor: 14.307

8.  Generation of germline-competent induced pluripotent stem cells.

Authors:  Keisuke Okita; Tomoko Ichisaka; Shinya Yamanaka
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

9.  Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts.

Authors:  Masato Nakagawa; Michiyo Koyanagi; Koji Tanabe; Kazutoshi Takahashi; Tomoko Ichisaka; Takashi Aoi; Keisuke Okita; Yuji Mochiduki; Nanako Takizawa; Shinya Yamanaka
Journal:  Nat Biotechnol       Date:  2007-11-30       Impact factor: 54.908

10.  Somatic coding mutations in human induced pluripotent stem cells.

Authors:  Athurva Gore; Zhe Li; Ho-Lim Fung; Jessica E Young; Suneet Agarwal; Jessica Antosiewicz-Bourget; Isabel Canto; Alessandra Giorgetti; Mason A Israel; Evangelos Kiskinis; Je-Hyuk Lee; Yuin-Han Loh; Philip D Manos; Nuria Montserrat; Athanasia D Panopoulos; Sergio Ruiz; Melissa L Wilbert; Junying Yu; Ewen F Kirkness; Juan Carlos Izpisua Belmonte; Derrick J Rossi; James A Thomson; Kevin Eggan; George Q Daley; Lawrence S B Goldstein; Kun Zhang
Journal:  Nature       Date:  2011-03-03       Impact factor: 49.962

View more
  9 in total

Review 1.  Preclinical studies for induced pluripotent stem cell-based therapeutics.

Authors:  John Harding; Oleg Mirochnitchenko
Journal:  J Biol Chem       Date:  2013-12-20       Impact factor: 5.157

2.  Genetic instability of modified stem cells - a first step towards malignant transformation?

Authors:  Doris Steinemann; Gudrun Göhring; Brigitte Schlegelberger
Journal:  Am J Stem Cells       Date:  2013-03-08

Review 3.  Achilles' heel of pluripotent stem cells: genetic, genomic and epigenetic variations during prolonged culture.

Authors:  Paola Rebuzzini; Maurizio Zuccotti; Carlo Alberto Redi; Silvia Garagna
Journal:  Cell Mol Life Sci       Date:  2016-03-09       Impact factor: 9.261

Review 4.  Embryonic stem cells or induced pluripotent stem cells? A DNA integrity perspective.

Authors:  Qiang Bai; Romain Desprat; Bernard Klein; Jean-Marc Lemaître; John De Vos
Journal:  Curr Gene Ther       Date:  2013-04       Impact factor: 4.391

Review 5.  c-MYC-induced genomic instability.

Authors:  Alexandra Kuzyk; Sabine Mai
Journal:  Cold Spring Harb Perspect Med       Date:  2014-04-01       Impact factor: 6.915

6.  Fast quantitative real-time PCR-based screening for common chromosomal aneuploidies in mouse embryonic stem cells.

Authors:  Charlotte D'Hulst; Irena Parvanova; Delia Tomoiaga; Maria L Sapar; Paul Feinstein
Journal:  Stem Cell Reports       Date:  2013-09-26       Impact factor: 7.765

7.  Recurrent transcriptional clusters in the genome of mouse pluripotent stem cells.

Authors:  Stavroula Skylaki; Simon R Tomlinson
Journal:  Nucleic Acids Res       Date:  2012-07-12       Impact factor: 16.971

8.  A subset of Drosophila Myc sites remain associated with mitotic chromosomes colocalized with insulator proteins.

Authors:  Jingping Yang; Elizabeth Sung; Paul G Donlin-Asp; Victor G Corces
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

9.  SIRT1 is necessary for proficient telomere elongation and genomic stability of induced pluripotent stem cells.

Authors:  Maria Luigia De Bonis; Sagrario Ortega; Maria A Blasco
Journal:  Stem Cell Reports       Date:  2014-04-17       Impact factor: 7.765

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.